← vista completa

Publicado el 1 de agosto de 2004 | http://doi.org/10.5867/medwave.2004.07.2248

¿Es posible evitar las transfusiones de sangre en la anemia del prematuro?

Is it possible to avoid blood transfusions in the anemia of prematurity?

Manuel Becerra Tamarín

Esta obra de Medwave está bajo una licencia Creative Commons Atribución-NoComercial 3.0 Unported. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

Autores

Manuel Becerra Tamarín

Figures

Article has no figures.

Foro

No hay mensajes

Historial

Citación Becerra Tamarín M. Is it possible to avoid blood transfusions in the anemia of prematurity?. Medwave 2004;4(07):e2248 doi: 10.5867/medwave.2004.07.2248

Publicación 01/08/2004

Métricas del artículo

Artículo no tiene métricas.

Notas

Referencias

  1. Maier RF, Sonntag J, Walka MM, Liu G, Metze BC, Obladen M. Changing practices of red blood cell transfusions in infants with birth weights less than 1000 g. J Pediatr. 2000 Feb;136(2):220-4. | CrossRef | PubMed
  2. Widness JA. Pathophysiology, diagnosis, and prevention of neonatal anemia. NeoReviews. 2000 Apr;1(4): e61-e68. | CrossRef
  3. Ohls RK. Manegement of the Anemia of Prematurityusing Human Recombinant Erythroietin. Transfus Altern Transfus Med. 2000 Feb;4(1):14-19. | CrossRef
  4. Zanjani ED, Pixley JS, Slotnick N, MacKintosh FR, Ekhterae D, Clemons G. Erythropoietin does not cross the placenta into the fetus. Pathobiology. 1993;61(3-4):211-5. | CrossRef | PubMed
  5. Zanjani ED, Poster J, Burlington H, Mann LI, Wasserman LR. Liver as the primary site of erythropoietin formation in the fetus. J Lab Clin Med. 1977 Mar;89(3):640-4. | PubMed
  6. Martin RJ, Fanaroff AA, Walsh MC. The blood and hematopoietic system. En: Fanaroff & Martin’s Neonatal–Perinatal Medicine. St. Louis, Missoouri: Mosby, 1997.
  7. Riegel KP. Respiratory gas transport characteristic of blood and hemoglobin. En: Physiology of the Neonatal Period. New York: Appleton-Century-Crafts, 1970.
  8. Pearson HA. Disorders of hemoglobin synthesis and metabolism. En: Hematologic Problems in the newborn. Philadelphia: Saunders, 1982:253.
  9. Thomas RM, Canning CE, Cotes PM, Linch DC, Rodeck CH, Rossiter CE, et al. Erythropoietin and cord blood haemoglobin in the regulation of human fetal erythropoiesis. Br J Obstet Gynaecol. 1983 Sep;90(9):795-800. | CrossRef | PubMed
  10. Widness JA, Philipps AF, Clemons GK. Erythropoietin levels and erythropoiesis at birth in infants with Potter syndrome. J Pediatr. 1990 Jul;117(1 Pt 1):155-8. | CrossRef | PubMed
  11. Ohls RK. The use of erythropoietin in neonates. Clin Perinatol. 2000 Sep;27(3):681-96. | CrossRef | PubMed
  12. Cohen A, Manno C. Transfusion practices in infants receiving assisted ventilation. Clin Perinatol. 1998 Mar;25(1):97-111. | PubMed
  13. Lundström U, Siimes MA, Dallman PR. At what age does iron supplementation become necessary in low-birth-weight infants? J Pediatr. 1977 Dec;91(6):878-83. | CrossRef | PubMed
  14. Keyes WG, Donohue PK, Spivak JL, Jones MD Jr, Oski FA. Assessing the need for transfusion of premature infants and role of hematocrit, clinical signs, and erythropoietin level. Pediatrics. 1989 Sep;84(3):412-7. | PubMed
  15. Cardemil G. Cirugía, perioperatorio y sangre. Rev Chilena de Cirugía. 2003 Jun;555(3):216-224.
  16. Brown MS, Garcia JF, Phibbs RH, Dallman PR. Decreased response of plasma immunoreactive erythropoietin to "available oxygen" in anemia of prematurity. J Pediatr. 1984 Nov;105(5):793-8. | CrossRef | PubMed
  17. Rhondeau SM, Christensen RD, Ross MP, Rothstein G, Simmons MA. Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors from infants with the "anemia of prematurity". J Pediatr. 1988 Jun;112(6):935-40. | CrossRef | PubMed
  18. Blanchette V, Zipursky A. Neonatal Hematology. En: Neonatology: Pathophysiology and Manegement of the newborn. Philadelphia: Lippincott, 1987:638-686.
  19. Kurtz A, Zapf J, Eckardt KU, Clemons G, Froesch ER, Bauer C. Insulin-like growth factor I stimulates erythropoiesis in hypophysectomized rats. Proc Natl Acad Sci U S A. 1988 Oct;85(20):7825-9. | CrossRef | PubMed
  20. Shannon KM. Anemia of prematurity: progress and prospects. Am J Pediatr Hematol Oncol. 1990 Spring;12(1):14-20. | CrossRef | PubMed
  21. Lachance C, Chessex P, Fouron JC, Widness JA, Bard H. Myocardial, erythropoietic, and metabolic adaptations to anemia of prematurity. J Pediatr. 1994 Aug;125(2):278-82. | CrossRef | PubMed
  22. Hunter N, Foster J, Chong A, McCutcheon S, Parnham D, Eaton S, et al. Transmission of prion diseases by blood transfusion. J Gen Virol. 2002 Nov;83(Pt 11):2897-905. | PubMed
  23. Dodd RY. Emerging infections, transfusion safety, and epidemiology. N Engl J Med. 2003 Sep 25;349(13):1205-6. Epub 2003 Sep 18. | CrossRef | PubMed
  24. Pealer LN, Marfin AA, Petersen LR, Lanciotti RS, Page PL, Stramer SL, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med. 2003 Sep 25;349(13):1236-45. Epub 2003 Sep 18. | CrossRef | PubMed
  25. Sazama K. Bacteria in blood for transfusion. A review. Arch Pathol Lab Med. 1994 Apr;118(4):350-65. | PubMed
  26. División de Desarrollo de Sistemas y Servicios de Salud, Programa de Medicamentos Esenciales y Tecnología, Servicios de Laboratorios de Salud Pública y Sangre. Medicina Transfusional en América Latina. 1994-2000. Washington, D.C.: OPS, 2001.
  27. Moroff G, Luban NL. Prevention of transfusion-associated graft-versus-host disease. Transfusion. 1992 Feb;32(2):102-3. | CrossRef | PubMed
  28. De Halleux V, Truttmann A, Gagnon C, Bard H. The effect of blood transfusion on the hemoglobin oxygen dissociation curve of very early preterm infants during the first week of life. Semin Perinatol. 2002 Dec;26(6):411-5. | CrossRef | PubMed
  29. Tin W, Milligan DW, Pennefather P, Hey E. Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation. Arch Dis Child Fetal Neonatal Ed. 2001 Mar;84(2):F106-10. | CrossRef | PubMed
  30. Ohls RK. Erythropoietin treatment in extremely low birth weight infants: blood in versus blood out. J Pediatr. 2002 Jul;141(1):3-6. | CrossRef | PubMed
  31. Kinmond S, Aitchison TC, Holland BM, Jones JG, Turner TL, Wardrop CA. Umbilical cord clamping and preterm infants: a randomised trial. BMJ. 1993 Jan 16;306(6871):172-5. | CrossRef | PubMed
  32. Garcia MG, Hutson AD, Christensen RD. Effect of recombinant erythropoietin on "late" transfusions in the neonatal intensive care unit: a meta-analysis. J Perinatol. 2002 Mar;22(2):108-11. | CrossRef | PubMed
  33. Kotto-Kome AC, Garcia MG, Calhoun DA, Christensen RD. Effect of beginning recombinant erythropoietin treatment within the first week of life, among very-low-birth-weight neonates, on "early" and "late" erythrocyte transfusions: a meta-analysis. J Perinatol. 2004 Jan;24(1):24-9. | CrossRef | PubMed
  34. Maier RF, Obladen M, Müller-Hansen I, Kattner E, Merz U, Arlettaz R, et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. J Pediatr. 2002 Jul;141(1):8-15. | CrossRef | PubMed
  35. Ohls RK, Osborne KA, Christensen RD. Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomized, placebo-controlled trial. J Pediatr. 1995 Mar;126(3):421-6. | CrossRef | PubMed